You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Cervical cancer

Topotecan for the treatment of recurrent and stage IVB cervical cancer

  • Technology appraisal guidance
  • Reference number: TA183
  • Published:  28 October 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders Appendix A: provisional matrix of stakeholders
10 September 2012
(63.58 Kb 18 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 06 September 2012

Back to top